Skip to content

Opening book details…

Can I read Post-treatment FDG PET-CT in head and neck carcinoma: comparative analysis of 4 qualitative interpretative criteria in a large patient cohort on EtoBox?

Post-treatment FDG PET-CT in head and neck carcinoma: comparative analysis of 4 qualitative interpretative criteria in a large patient cohort by Zhong, Jim; Sundersingh, Moses; Dyker, Karen; Currie, Stuart; Vaidyanathan, Sriram; Prestwich, Robin; Scarsbrook, Andrew is a Biochemistry, Genetics and Molecular Biology article available to read on EtoBox.

What is Post-treatment FDG PET-CT in head and neck carcinoma: comparative analysis of 4 qualitative interpretative criteria in a large patient cohort about?

There is no consensus regarding optimal interpretative criteria (IC) for Fluorine-18 fluorodeoxyglucose (FDG) Positron Emission Tomography – Computed Tomography (PET-CT) response assessment following (chemo)radiotherapy (CRT) for head and neck squamous cell carcinoma (HNSCC). The aim was to compare accuracy of IC (NI-RADS, Porceddu, Hopkins, Deauville) for predicting loco-regional control and progression free survival (PFS). All patients with histologically confirmed HNSCC treated at a specialist cancer centre with curative-intent non-surgical treatment who underwent baseline and response assessment FDG PET-CT between August 2008 and May 2017 were included. Metabolic response was assessed using 4 different IC harmonised into 4-point scales (complete response, indeterminate, partial response, progressive disease). IC performance metrics (sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), accuracy) were compared. Kaplan-Meier and Cox proportional hazards regression analyses were performed for survival analysis. 562 patients were included (397 oropharynx, 53 hypopharynx, 48 larynx, 64 other/unknown primary). 420 patients (75%) received CRT and

Who reads Post-treatment FDG PET-CT in head and neck carcinoma: comparative analysis of 4 qualitative interpretative criteria in a large patient cohort?

It is typically read by researchers, students, and practitioners in Biochemistry, Genetics and Molecular Biology.

Author
Zhong, Jim; Sundersingh, Moses; Dyker, Karen; Currie, Stuart; Vaidyanathan, Sriram; Prestwich, Robin; Scarsbrook, Andrew
Publisher
Springer Science and Business Media LLC; London: Nature Publishing Group; [London]: Springer Nature; Nature Publishing Group; Society for Mining, Metallurgy and Exploration Inc.; Research Square; Springer Nature; Island Press (ISSN 2045-2322)
Published
2020
Language
EN
Field
Biochemistry, Genetics and Molecular Biology (Life Sciences)

More by Zhong, Jim; Sundersingh, Moses; Dyker, Karen; Currie, Stuart; Vaidyanathan, Sriram; Prestwich, Robin; Scarsbrook, Andrew

Browse all works by Zhong, Jim; Sundersingh, Moses; Dyker, Karen; Currie, Stuart; Vaidyanathan, Sriram; Prestwich, Robin; Scarsbrook, Andrew